{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:28:50Z","timestamp":1760956130450,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.chest.2021.06.023","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T12:18:29Z","timestamp":1633436309000},"page":"1160-1162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Benefits of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers on Progression of Emphysema and Lung Function Decline"],"prefix":"10.1016","volume":"160","author":[{"given":"Xander","family":"Bertels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lies","family":"Lahousse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2021.06.023_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1411532","article-title":"Lung-function trajectories leading to chronic obstructive pulmonary disease","volume":"373","author":"Lange","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2021.06.023_bib2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","article-title":"Changes in forced expiratory volume in 1 second over time in COPD","volume":"365","author":"Vestbo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2021.06.023_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1164\/rccm.201911-2115OC","article-title":"Lung function trajectories leading to chronic obstructive pulmonary disease as predictors of exacerbations and mortality","volume":"202","author":"Marott","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2021.06.023_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02146-2017","article-title":"Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype","volume":"51","author":"Celli","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2021.06.023_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1148\/radiol.2021203531","article-title":"Relationship between emphysema progression at CT and mortality in ever-smokers: results from the COPDGene and ECLIPSE cohorts","volume":"299","author":"Ash","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.chest.2021.06.023_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1249\/MSS.0000000000001859","article-title":"Physical activity is associated with attenuated disease progression in chronic obstructive pulmonary disease","volume":"51","author":"Demeyer","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.chest.2021.06.023_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","article-title":"Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study","volume":"178","author":"Celli","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.06.023_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1513\/AnnalsATS.201604-317OC","article-title":"Angiotensin-converting inhibitors and angiotensin ii receptor blockers and longitudinal change in percent emphysema on computed tomography. the multi-ethnic study of atherosclerosis lung study","volume":"14","author":"Parikh","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.chest.2021.06.023_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1378\/chest.13-0799","article-title":"Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use","volume":"145","author":"Petersen","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2021.06.023_bib10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.chest.2021.05.007","article-title":"Emphysema progression and lung function decline among angiotensin converting enzyme inhibitors and angiotensin-receptor blockade users in the COPDGene Cohort","volume":"160","author":"Tejwani","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.chest.2021.06.023_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S2213-2600(14)70002-5","article-title":"Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis","volume":"2","author":"Cho","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.chest.2021.06.023_bib12","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa1403086","article-title":"Simvastatin for the prevention of exacerbations in moderate-to-severe COPD","volume":"370","author":"Criner","year":"2014","journal-title":"N\u00a0Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922101165X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922101165X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:35:50Z","timestamp":1757925350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236922101165X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S001236922101165X"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.06.023","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefits of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers on Progression of Emphysema and Lung Function Decline","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.05.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}